nxp800
nxp800: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Nuvectis Pharma, Inc. (NVCT) | Phase 1 |
Clinical Trials (1)
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
Frequently asked questions
Who is developing nxp800?
nxp800 is being developed by Nuvectis Pharma, Inc..
How many clinical trials involve nxp800?
BioSniper tracks 1 clinical trial involving nxp800.
Get deeper analysis on nxp800
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis